RxDoctor Payments Data

Steven Monte, MD

Anatomic Pathology & Clinical Pathology · Drexel Hill, PANPI 1104850056

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 54 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 14 manufacturers, the largest accounting for just 23.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $663 and has fallen 92.1% since, to $52 in 2025.

$849in general payments, 2019–2025

Across 54 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$201
  • Bristol Myers Squibb$175
  • Eisai Inc.$95
  • E.r. Squibb & Sons, L.L.C.$65
  • Puma Biotechnology, Inc.$63
  • Johnson & Johnson$51
  • plus $200 from 8 others

What the payments were for

  • Food & beverage$849100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$849 in reported general payments places this provider in the 85th percentile of 357 anatomic pathology & clinical pathology providers in Pennsylvania.

See all anatomic pathology & clinical pathology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$2,314
Medicare patients
14
Services billed
53

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other anatomic pathology & clinical pathology in Drexel Hill

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →